In short. The infraorbital vessels sit close to the target plane, and a lump in thin skin is visible here in a way it is not elsewhere on the face.

Key points

  • Ask what is kept on site for a vascular problem, and who is available if one happens outside clinic hours.
  • Ask what happens next if the skin does not recover in the first hour.
  • Those two answers describe the setting more accurately than anything on a brochure.

Two risks belong specifically to this area, and both are consequences of anatomy rather than of any product. One is vascular and time-critical. The other is that a lump placed under the thinnest skin on the face can be seen in a way a lump anywhere else cannot.

The vessels close to the target plane

The infraorbital artery and its branches run near the plane material is placed in for the tear trough. Material entering one of them can travel, and the direction it can travel in reaches the circulation around the eye. Skin can be lost to the tissue it reaches, and in rare cases vision is affected. This is an emergency rather than a cosmetic problem, and the outcome depends on how quickly it is recognised.

What recognition requires

Severe pain out of proportion to the injection, or skin changing colour, needs immediate assessment, and any change in vision needs emergency care. The treatment that can reverse a vascular problem in the reversible class of material only works if it is given early, which is why the question is not whether the enzyme is owned but whether a plan for the first ten minutes exists.

Two questions that decide the setting

Ask what is kept on site for a vascular problem, and who is available if one happens outside clinic hours. Ask what happens next if the skin does not recover in the first hour. Those two answers describe the setting more accurately than anything on a brochure.

Lumps in thin skin

In the cheek a small lump can sit unseen. Under the eye it is visible, and it is visible in specific ways: as a firm area in the first weeks that usually softens, as a discrete nodule that remains at the review, as a ridge along the track the material was placed in, or as a lump that appears only when you smile or look up because it moves with the muscle. Each is managed differently, and pressing or massaging the area yourself reliably makes it worse.

Delayed reactions and accumulation

A delayed inflammatory reaction can appear weeks or months after treatment, sometimes after an unrelated illness, a dental procedure or a vaccination. The slower risk is accumulation: repeated sessions in a region that drains poorly raise the baseline until the under-eye is puffy in a way that no longer resolves, and that puffiness is itself read as a bag.

Emergency signs, during or after

  • Severe pain out of proportion to the injection, or pain that worsens rather than settles.
  • Skin turning white, grey, mottled or dusky anywhere near the treated area.
  • Any change in vision, including blurring or a patch of lost sight.

How the depth and the amount are chosen to keep material away from the surface is in Thin Skin and the Risk of a Grey Tint. What can be taken back afterwards is in What Tear Trough Filler Cannot Undo, and how safety is organised inside the hospital is on the quality and surgical safety pages.

Related reading

Frequently asked questions

What should be in place before the first injection?

A named person who assesses you if the skin changes colour, a way to reach that person out of hours, and immediate access to the treatment that breaks down the reversible class of material. A setting that cannot describe those three things clearly is not the setting for this treatment.

Do lumps under the eye go away on their own?

Some do. Early firmness in the first weeks often softens as the material settles into the tissue. A discrete lump that is still there at the review, or one that becomes visible only when you smile or look up, is a different finding and is assessed rather than given more time. Pressing or massaging it yourself does not help.

Can a blunt cannula remove the vessel risk?

No. A cannula reduces the chance of entering a vessel directly, and it does not remove the risk, because the vessels here vary in position and a cannula can still deliver material into the circulation. It changes the odds rather than removing the problem, and that is why the setting matters as much as the instrument.

Risks & Limitations

  • The infraorbital vessels run close to the plane the material is placed in, and their position varies between people. Material entering one can travel toward the circulation around the eye: skin can be lost, and in rare cases vision is affected. This is time-critical rather than cosmetic.
  • The lower lid is the thinnest skin on the face, so material placed too near the surface can show through it as a grey or blue-grey tint, and a lump here is visible in a way a lump in the cheek or the jaw is not. Only the reversible class can be broken down, and dissolving is its own procedure with its own risks rather than a clean undo.
  • This region drains the worst on the face. Swelling lasts longer here than anywhere else, morning puffiness can persist for months, and repeated filling raises the baseline until the under-eye is puffy in a way that reads as a bag.
  • Filling a bulge makes it worse: material placed beneath a herniated fat pad raises the surface around a mound that is still there, and the eye reads heavier rather than rested. Where the finding is a fat pad, the treatment that addresses it is an operation.

When to Seek Care

  • Any change in vision, including blurring or a patch of lost sight — seek emergency care immediately.
  • Severe pain out of proportion to the injection, or pain that is worsening rather than settling.
  • Skin turning white, grey, mottled or dusky anywhere near the treated area.
  • Swelling that is increasing after the first few days rather than settling, or fever with spreading redness, warmth or discharge.

References & Further Reading

  • American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
  • National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
  • Cochrane Library — systematic reviews
  • Chinese Medical Association Plastic Surgery Branch — clinical guidance

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.